Danish scientists raise alarm after discovering link between Bayer drug and brain cancer

The drug Androcur from German pharmaceutical giant Bayer has resulted in severe side effects on several occasions, when patients developed a lethal type of brain cancer after receiving the drug. Researchs raise alarm and call for the DMA to reassess its recommendation, while Bayer is silent.

Photo: Bayer / PR

German pharmaceutical company Bayer might soon be the center of an impending scandal.

Researchers at Copenhagen-based hospital Rigshospitalet have documented a clear link between the drug Androcur (cyproterone acetate) from Bayer and a serious type of cancerous brain tumor known as meningioma, which are potentially lethal tumors in the brain membrane that usually require surgical removal.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs